White Paper

The ABCs of Drug Pricing

The ABCs of Drug Pricing

Drug pricing can be utterly complex. Starting from the drug’s research to selling at the pharmacy, numerous factors and variables impact the actual cost of a drug. Meanwhile, competition has spurred private players to seek their own cost benchmarking methods. 

So, what’s the best way to achieve realistic drug pricing amid an economy that is poised to reopen?

In this extract from a recent webcast by Wolters Kluwer, you will explore: 

  • Common terms and acronyms used in drug pricing (AWP, FUL, ASP, etc.)
  • Role of data on decision-making across the supply chain
  • Drug pricing trends and their impact on innovation, research, and cost

  This page is FastPass tested and is compliant with Microsoft Accessibility features.

Grab Your White Paper